Jung H. Kwon
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 128 publications
Magnetic Resonance-Guided Radiotherapy for Unresectable Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Case Series and Review of Treatment Options.
Journal: Current oncology (Toronto, Ont.)
Published: June 17, 2026
Shear wave elastography demonstrates similar risk stratification performance to vibration-controlled transient elastography in FIB-4-based two-step algorithms for MASLD.
Journal: Hepatology (Baltimore, Md.)
Published: May 07, 2026
Regorafenib as Second-Line Versus Later-Line Therapy in Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study with Exploratory Analysis of Prior Immune Checkpoint Inhibitor Exposure.
Journal: Targeted oncology
Published: April 18, 2026
Shear Wave Elastography Combined with ALBI Score Enhances Prediction of Hepatic Decompensation in Chronic Liver Disease.
Journal: JHEP reports : innovation in hepatology
Published: March 04, 2026
Whole-genome sequencing reveals genetic diversity, population structure, and core collection construction in Korean peach (Prunus persica) germplasm.
Journal: Frontiers in plant science
Published: September 10, 2025
Liver Stiffness Measured by Vibration-Controlled Transient Elastography Predicts Hepatic Decompensation in Patients with Hepatocellular Carcinoma Receiving Systemic Treatments.
Journal: Liver cancer
Published: September 10, 2025
Challenges of an EMR-Based Hospital Alert Program for Micro-Elimination of Hepatitis C in Tertiary Referral Hospitals.
Journal: Journal of viral hepatitis
Published: September 09, 2025
Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumab.
Journal: Hepatology (Baltimore, Md.)
Published: March 04, 2025
Peripheral blood inflammatory score using a cytokine multiplex assay predicts clinical outcomes in patients treated with atezolizumab-bevacizumab for unresectable HCC.
Journal: Frontiers in immunology
Published: February 17, 2025
Subset of Child-Pugh Score 7 Shows Comparable Survival Outcomes to Child-Pugh Score 6 in Patients with Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 10, 2025
Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study.
Journal: Annals of medicine
Published: January 24, 2025
Last Updated: 09/26/2026